AI drug discovery is moving from experimental research projects into the pipelines of major pharmaceutical companies. Chai Discovery has partnered with Bristol Myers Squibb (BMS) to use AI models for therapeutic antibody discovery, giving the drugmaker access to Chai’s molecular prediction and design technology as BMS builds what it describes as a continuously learning, AI-powered... Read More



